HeyJaredAlex Philippidis
- Indexed articles, last 90 days
- 2
- Latest publication
- Aug 3, 2026
- Outlet visibility, for Genetic Engineering and Biotechnology News
- Top 5M sites
- Earliest in this view
- Jul 5, 2026
Latest articles
StockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel (opens the original)
Read excerpt
After seeing its lead candidate rejected by the FDA last year, Capricor Therapeutics is hoping for a better outcome for its resubmitted BLA for its lead pipeline candidate Deramiocel. The post StockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel appeared first on GEN - Genetic Engineering and Biotechnology News.
StockWatch: New UC Data Sparks Smoother Sailing for Abivax (opens the original)
Read excerpt
Less than a month after its stock roller-coastered on safety signals associated with its late-stage ulcerative colitis (UC) drug candidate obefazimod, shares of Abivax (Euronext Paris and Nasdaq: ABVX) enjoyed smoother sailing this past week—namely a 63% surge in Europe and a 50% leap in the United States over four trading days, following more positive data that appeared to reassure investors. The post StockWatch: New UC Data Sparks Smoother Sailing for Abivax appeared first on <a href="https://
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Genetic Engineering and Biotechnology News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.